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doi:10.1016/j.hkpj.2011.02.002Abstract This study aimed to determine the whole-body vibration (WBV) frequencies that
cause the highest average electromyogram (EMG) output in four different muscles, in relation
to patients suffering from multiple sclerosis (MS), and to what extent the loads were accept-
able. In a series of measures using different WBV frequencies applied to five MS patients, the
effects on EMG output (in mV) and the rate of perceived exertion (RPE; scale, 6e20) were
studied. All measurements were performed on two different WBV devices: the ZeptorMed
and the Galileo2000. The physical loads were well accepted, with a highest average rate
of perceived exertion of 12.8 during the 29-Hz application. With the Galileo2000, the highest
EMG results were obtained at 29 Hz in the vastus medialis and lumbar muscles, at 25 Hz in the
gastrocnemius medialis, and at 19 Hz in the tibialis anterior muscle. The results with the
ZeptorMed were more consistent at 11 Hz and 12 Hz, but the EMG output was lower. In
conclusion, the physical loads of WBV were well accepted by the MS patients. However, the
most effective frequencies are device specific and should be determined for each subject
and for each individual muscle or muscle group.
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Multiple sclerosis (MS; encephalomyelitis disseminata) has
a substantial physical and physiological impact on those
suffering from this disease. The incidence rate in Switzerland
is approximately four new diagnosed cases of MS per 100,000
inhabitants per year, with a total of 10,000 patients in
Switzerland and around 2.5 million worldwide [1].served.
13MS is a chronic autoimmune disease, which mainly, but
not exclusively, affects the central nervous system. Primary
demyelination has also been found in the peripheral
nervous system [1]. For example, in all of the cases of
“acute multiple sclerosis” described by Marburg [2], thor-
ough investigation of the patients revealed outbreaks of the
disease in the peripheral and central nervous system.
Although the disease was first described as a clinical
entity (“Histologie de la sclerose en plaques”) [3] in 1868 by
Jean-Martin Charcot (1825e1893), its cause remains
unknown. So-called slow viruses [1], genetic predisposition
[4], and recently presented chronic cerebrospinal venous
insufficiency [5] are the possible causes of this disease.
There are two main classifications of MS: progressive
(primary and secondary) and relapsing remitting MS (RRMS).
After about 10 years, approximately 50% of people with
RRMS go on to develop secondary progressive MS (SPMS).
Many new drug therapies have been successful in treating
the symptoms of people with RRMS [6]. However, studies
have indicated that SPMS does not respond so well, if at all,
to the medications used to treat RRMS [7].
The lack of effective drug therapies for people with SPMS
increases the need to discover successful treatments to
improve their quality of life. In relation to rehabilitation and
research, the effects of resistance training and, more
recently, whole-body vibration (WBV), on neurological
patients, have been emerging areas, thoughWBV is not a new
application. In 1892, Jean-Martin Charcot presented a study
[8] in which he stated that vibrations applied to the skin,
joints, or the whole body could be useful in ameliorating
a number of neurological disorders. Charcot mainly focused
on the treatment of people with Parkinson’s disease (PD),
based on anecdotal reports from patients suffering from this
disease who claimed to have experienced “great relief from
prolonged journeys by railroad and carriage.” To simulate
the rocking of the carriage cars, he devised a vibrating
armchair, known as the “Fauteuil Trepidant.”
Although the exact parameters used by Charcot are not
known, he described giving his patients daily sessions in the
vibration chair lasting 30 minutes and with varying inten-
sities depending on individual tolerance. Charcot was able
to modify the frequency, direction, and intensity of the
vibrations and was sensitive to the responses of his
patients, stating that “. PD patients react individually
and, therefore, it is essential to tailor the treatment
according to each subject” [8].
Charcot reported demonstrable improvements after five
or six sessions. Although this treatment was supposed to be
a therapy for shaking palsy, the tremor itself was not
greatly influenced. However, patients reported feelings of
greater lightness, less stiffness, and improved walking, as
well as improvements in parkinsonian nocturnal symptoms,
discomfort, and sleep impairment.
After Charcot’s death in 1893, his younger colleague,
Gilles de la Tourette, continued to pursue the vibratory
therapy. However, he moved away from WBV and, instead,
developed a motorised helmet to produce brain vibrations.
As Tourettes’s career did not last very long, vibratory
therapy ostensibly disappeared after the death of Charcot.
WBV therapy was rediscovered in the early 1990s and has
since made a remarkable comeback as an additional
training tool for both healthy and impaired subjects.Research in this area is now widespread and popular, not in
the least because of a bed rest study carried out in Berlin
[9,10], which studied the effects of WBV in situations of
sub-gravity. The Berlin study mainly focused on mineral
bone density, muscle strength, and power, as these physi-
ological properties are heavily threatened during long-term
spaceflight and a two-year flight to mars, which is planned
for the near future.
In general, the beneficial effects of WBV training are
widely accepted and recognised in sports and in rehabili-
tation [11e13]. Although the therapeutic effects of WBV on
elderly, postmenopausal women and neurological patients
are very promising, research in these areas specific to
neurological patients is lacking [14]. Several researchers
[15e20] have focused mainly on patients with PD. However,
studies with MS patients are very rare. Schuhfried et al
[21], in 2005, and Biland et al [22] and Schyns et al [23], in
2009, reported promising results, but the numbers of
participants were small and the dropout rates were high.
Another problem in this area is the lack of prescriptions for
WBV training. Schuhfried et al [21], Haas et al [16], Tur-
banski et al [19,24], and Biland et al [22] used the same
type of vibration device (the ZeptorMed) [25], which has
a frequency range of 1e12 Hz, an amplitude of 3 mm, and
1- to 90-second intervention time. These studies used low
frequencies of around 3 Hz during five bouts of 60-second
WBV, with 1-minute rest between bouts. The decision
regarding which frequency was used was primarily based on
the patients’ subjective reports. The intervention time (of
around 60 seconds) and the amplitude (around 3 mm) were
chosen by the researchers.
Schyns et al [23] used the VibroGym [26] with
a frequency range of 30e50 Hz, 2- to 4-mm amplitude, and
an intervention period of 30e60 seconds, which started and
ended with 60-second warm-up and cool-down, respec-
tively, at 50-Hz frequency and 2-mm amplitude. The exer-
cise bout consisted of one 30-second bout with 40-Hz
frequency and 2-mm amplitude. No rest periods were
provided between the different bouts.
Several studies with healthy subjects [27,28] tried to
determine the most effective frequencies for activating
individual muscles or muscle groups with WBV. Jackson [29]
compared two different vibration frequencies (2 Hz and
26 Hz) to determine which parameter had the maximum
effect on isometric strength in MS patients. They used the
Maxuvibe [30], which is based on the same principles as
the Galileo devices (5e30 Hz, alternating tilting plate and
0- to 5.2-mm amplitude) [31]. Although not significant, they
found a consistent trend of higher torque values for the
quadriceps and hamstring muscles after the 26-Hz inter-
vention and compared with the 2-Hz condition.
The muscles tested in the foregoing studies were mainly
the vastus medialis, erector truncae, tibialis anterior, and
gastrocnemius medialis. These muscles play an important
role in extension activities, such as standing up and
walking. In medical and physiotherapeutic treatments for
MS patients, the ability to maintain extension activities is
the most important rehabilitation goal.
As our study focused on the muscular benefits of WBV,
the most effective frequency was defined as the frequency
that caused the highest electromyogram (EMG) output
measures (in mV). It is thought that this frequency may
Table 1 Specifications of the wireless EMG device (Kine-
Pro) according to the manufacturer (www.kine.is)
Specifications of the
KinePro EMG device
Transmitter output power 0.1e10 mW
Radio bandwidth per channel 100 kHz
Transmission frequency 433.05e434.79 MHz
ISM band
Number of channels 1e12
Radio range 50 m
Sampling frequency 1562.5 Hz
Signal bandwidth 10e500 Hz
Input impedance 10 GO
Sensitivity 4 mV
Output format digital RS232
Electrode placement Triode with electrodes
20 mm apart
EMGZ electromyogram; ISM Band = industrial, scientific and
medical band.
14 K.H. Madoucause an increase of maximum force and/or power in that
particular muscle or muscle group, triggered by stretch
reflexes. This may not necessarily be the only goal of
a therapeutic vibration intervention, as very low frequen-
cies also have muscular effects because of other mecha-
nisms, such as the triggering of the otoliths [28].
The main goal of this research was to determine the
most effective WBV frequencies of two different vibration
platforms and the rate of perceived exertion (RPE) of four
different muscles, the vastus medialis, erector truncae,
tibialis anterior, and the gastrocnemius medialis. It is
generally accepted that the application of WBV is respon-
sible for additional muscular activity. Therefore, we
hypothesised that higher frequencies would cause higher
levels of muscular activity.
Although amplitude and resonance are also variables to
be considered in rehabilitation and in future studies, in this
study, we focused exclusively on frequency and on the RPE
using the Borg Scale (range, 6e20). Although finding the
frequency with the highest EMG output was the main goal
of our research, ethical and health reasons led us to decide
to make the RPE, as reported by the MS patients, the first
limitation criterion to be considered in our research, as
well as in future rehabilitation settings.
Furthermore, we hypothesised that the most effective
levels of vibration will vary between and within individualsFigure 1 Average EMG values of the vastus medialis muscle at allbecause the intensity and effectiveness of vibrations
depend on the mass, stiffness, and other properties of the
tissues, the distance of the tissues from the vibrating plate,
and the ability of the participant to activate damping
mechanisms [32e34].
If these hypotheses are true, this would imply that the
optimal parameters of WBV need to be determined not only
for each subject individually, but also for each muscle or
muscle group.
Methods
Subjects
Five patients with MS participated voluntarily in this study.
They were informed in detail about the study and the study
goals and signed an informed consent. All measures were
conducted in accordance with the declaration of Helsinki.
All of the participants were current patients in the outpa-
tient neurological and geriatric physiotherapy department
of the University Hospital Basel in Basel (Switzerland) and
were familiar with and currently undergoing WBV as
a physiotherapeutic intervention. Therefore, no ethical
approval was required.
Besides a history of MS, all participants were required to
be able to stand on the vibration platform without assis-
tance. To gain an indication of the participants’ functional
abilities, two functional tests, “timed up and go” (TUG) [35]
and the “chair rising test” [36], were performed before the
first vibration application. These tests are often used to
monitor therapeutic effects and the course of neurological
patients [35,37,38]. The participants started and finished
the tests sitting on a chair (sitting height, 43 cm) with
armrests and with their back against the back of the chair.
Both tests were performed without assistance and had to be
executed as fast as possible. Walking aids were allowed. In
the TUG, the participants stood up, walked 3 m, turned
around, walked back, and sat back again. The use of the
armrest was allowed. In the “chair rising test,” the partici-
pants stood up until the knees were fully extended and then
sat down again five times, without using the armrest.
Devices
The two different WBV devices used in this study were
the ZeptorMed (http://www.sr-therapiesysteme.eu/121.
html), which is described as a “stochastic resonancefrequencies on two different devices. EMGZ electromyogram.
Figure 2 Average EMG values of the lumbar erector muscle at all frequencies on two different devices. EMGZ electromyogram.
15training” device, and the Galileo2000 (Novotec Medical,
http://www.galileo-training.com/de-deutsch/start.html).
The ZeptorMed has two separately vibrating plates, with
3-mm amplitude and a frequency range of 1e12 Hz. The
Galileo2000 has one plate that alternates around a mid-
axis. The amplitude of the Galileo2000 depends on the
distance of the feet from the mid-axis, which results in an
amplitude range of 1e7 mm. The vibration frequency has
a 25-Hz range (5e30 Hz).
The “KinePro Wireless EMG-Device” (http://
hitechtherapy.ipcoweb.com/kine_pro), which has an
effective measuring distance of 50 m, was used to measure
muscular activity. This allows participants to move freely
without disturbance and being distracted by connection
cables. The KinePro Wireless EMG device measures and
records EMG output every 70 milliseconds, which means
that around 140 measures are recorded during a 10-second
application phase. To prevent error, the EMG signal is
digitised within 5 mm from the skin surface. Technical
specifications of this device are provided in Table 1.Recording procedures
All participants were measured on two occasions at the
same time of the day (4 PM) with 1 week between measures.
The triodes (triple electrodes with a 20-mm space) of the
wireless EMG device were placed on four different muscles
[vastus medialis, erector truncae (L3eL4), tibialis anterior,
and gastrocnemius medialis], using the guidelines of Konrad
[39] and those recommended by the manufacturer of the
EMG device.
Before applying the WBV, each participant performed
a static squat with knees slightly bent at a 20 angle toFigure 3 Average EMG values of the lumbar erector muscle at allrecord a baseline value and to become familiarised with
the correct body posture. To maintain this position during
the application of the vibration, the participants stood
facing a wall on which a marker indicated their eye level.
This was done to ensure a correct, consistent, and repro-
ducible body position. To provide optimum recovery and
minimum extra load, the participants were asked to sit
down during the one-minute rest period between the 10-
second applications.
During the first session, each frequency (1e12 Hz) of the
ZeptorMed was applied for 10 seconds, starting with the
lowest frequency possible, with 60-second rest between
applications. In total, 12 ten-second applications were
conducted. After each application, the participant rated
the physical load (RPE).
During the second session, the same procedure was used
with the Galileo2000. As this device has a 25-Hz range,
only every second frequency was applied, starting with the
lowest frequency (5 Hz) and ending with 29 Hz. In total, 13
ten-second applications were conducted, which closely
equates with the number of tests during the first session.
The EMG recording began 0.5 seconds after the start of
the vibration and was stopped around 0.5 seconds before
the application concluded. After each application, the
participants rated the physical load during the vibration
application using the Borg Scale, where 6 is the lowest and
20 is the highest rate possible. In addition, after each
vibration application, the participants were asked if they
wanted to continue to the next higher level. Despite the
possibility of sequence effects, it was decided to start with
the lowest frequency and to increase the rate successively,
rather than applying each frequency in a random order.
This setting enabled the participants to better estimate the
load during the next higher level. Thus, unexpected highfrequencies on two different devices. EMGZ electromyogram.
Figure 4 Average EMG values of the gastrocnemius medialis muscle at all frequencies on two different devices.
EMGZ electromyogram.
16 K.H. Madouloads and, subsequently, the risk of possible physical harm
were reduced to a minimum.
Data analysis
After each measurement, the results were converted into
an excel file. The mean and maximum EMG outputs in
mVolts as well as the time to maximum output were
calculated for each muscle and each vibration frequency in
each participant. The data of all participants were aver-
aged, which resulted in an EMG average for each muscle at
each frequency.
All of the averaged EMG data as well as the RPE with the
ZeptorMed and Galileo2000 were then listed and are
presented in graph form, as shown in Figs. 1e4.
Results
Subjects
Five MS patients [3 women and 2 men; age average, 41.4
years (16.95)] of the outpatient department of the
University Hospital physiotherapy centre in Basel
(Switzerland) volunteered to participate in this study. On
average, they had suffered from MS for 16.8 (12.03) years.
Two patients used walking aids. The participants’ func-
tional abilities differed substantially, as represented by
their “TUG” and “chair rising test” results (Table 2).Table 2 Overview of the participants (age and MS history in ye
during each performance, as an indication of the participants’ fu
Participants Age (yr) Walking aids MS history
P1 35 2 Canes 22
P2 23 None 6
P3 68 1 Cane 35
P4 35 None 14
P5 46 None 7
Mean 41.40 16.80
Standard deviation 16.95 12.03
CRtestZ “time of chair rising test”; MSZmultiple sclerosis; RPEZ rWBV and rate of perceived exertion
All participants finished all applications. Although the
RPE on the Galileo2000 was higher than that on the
ZeptorMed (average, 9.06 against 8.90), all participants
preferred the vibration applications on this device. Only
one patient reported a feeling of discomfort immediately
after the research sessions, but this lasted only for about
30 minutes. After that, the participant stated that he felt
more comfortable and relaxed, and this lasted for around
the next 4 days. The application with 29 Hz on the Gali-
leo2000 was rated the highest RPE (average, 12.8) (Fig. 5).
The highest rate on the ZeptorMed was on average 11.4
with 12 Hz. Although one participant rated up to 20, he
reported that this was bearable.
WBV and frequency
In this study, four different muscles were measured (Figs.
1e4). It appeared that every muscle had its own optimum
frequency and, as both devices produced different types of
vibrations with possibly different effects, the highest
results were determined for each device and each muscle
individually.
Overall, the Galileo2000 had the highest EMG outputs
on the vastus medialis and erector truncae muscles with
29 Hz, on the tibialis anterior muscle with 19 Hz, and on the
gastrocnemius medialis muscle with 25 Hz. The highest
results obtained with the ZeptorMed were with 11 Hz onars) and the results of the CRtest and the TUG and the RPE
nctional and physical abilities
(yr) CRtest (s) RPE CRtest TUG (s) RPE TUG
53.6 10 40.5 9
15.9 8 7.4 9
32.2 7 24.9 7
12.7 7 7.8 6
7.9 7 5.6 6
24.46 7.80 17.24 7.40
18.67 1.30 15.18 1.52
ate of perceived exertion; TUGZ “timed up and go.”
Figure 5 RPE during vibration applications and static squat without vibration. RPEZ rate of perceived exertion.
17the vastus medialis muscle (equal to the output with 29 Hz
on the Galileo2000), and with 12 Hz on all other muscles.
Although these results showed a clear tendency, the
differences between and within subjects should not be
ignored (Tables 3 and 4).
ZeptorMed
In 10 out of 20 cases, 12 Hz was themost effective frequency
with the ZeptorMed, whereas 11 Hz was the most effective
in seven cases. For the vastus medialis muscle, 11 Hz was the
most effective frequency (in four out of five cases). In
general, it can be stated that 11e12 Hz was the most
effective frequency, though in two out of 20 cases, 7 Hz was
the most effective one, and in another case, it was 9 Hz.
Galileo2000
With the Galileo2000, the most effective frequencies
varied considerably. On the lumbar erector muscle, the
higher frequencies (range, 23e29 Hz) caused the highest
outcomes. In all other three muscles, a greater range of
frequency variation was found, with a tendency towards
lower frequencies from around 20 Hz. The vastus medialis
muscle showed the largest variation (17e29 Hz).
Discussion
Although the frequencies varied greatly, with the
ZeptorMed, the frequencies of 11 Hz and 12 Hz were
clearly the most effective. Below 7 Hz, the effects of the
ZeptorMed were limited. It would be interesting to see
the effects with higher frequencies on this device, but
12 Hz is the highest frequency possible.
With the Galileo2000, the range between 21 Hz and
29 Hz was found to be the most effective, which was alsoTable 3 ZeptorMed frequencies (Hz) with the highest electro
Participants Vastus medialis Lumbar erector
P1 7 7
P2 11 12
P3 11 12
P4 11 12
P5 11 12the case in several other studies [11,23]. The results with
this device lend support to the conclusion that each muscle
has its own optimum frequency. Although the lumbar
muscles tended to show optimum reactions more consis-
tently toward the higher frequencies (greater than 25 Hz),
the reactions of the leg muscles varied considerably. On the
Galieo2000, frequencies of 17 Hz and above appeared to
be most effective.
In physiotherapeutic settings, WBV devices should be
used with caution. The choice of device and the target
muscle groups depend on the aim of the therapeutic
treatment. The vibration frequency should be adapted to
the individual patient and the intensities tailored to his or
her physical capacity, although the vibration loads were
well accepted in this study. With the Galileo2000 in
particular, the frequency should be determined for each
individual subject and his or her individual muscle groups,
especially as it appears that the EMG results had reached
their maximum level for the frequency range of this
device.
The aim of this study was to determine the most effec-
tive vibration load for four separate muscles. The author is
aware of the fact that the number of participants does not
ensure concrete conclusions. Nevertheless, although it is
clear that a single most effective frequency does not exist,
the conclusion that higher (25 Hz and higher), though not
the highest, frequencies cause higher EMG output appears
to be justified to some extent.
The reported RPE indicated that the load of WBV was
within the physical and physiological limits of the partici-
pants. However, this does not mean that WBV is suitable for
every MS sufferer. We, therefore, recommend including the
RPE in every WBV application when used for impaired
subjects.
WBV is an exciting area in the field of exercise and
medical science. To enable experts in this field to use this
application more efficiently and more effectively, themyogram output
Tibialis anterior Gastrocnemius medialis
11 11
9 12
12 12
12 12
11 12
Table 4 Galileo2000 frequency (Hz) with the highest electromyogram output
Participants Vastus medialis Lumbar erector Tibialis anterior Gastrocnemius medialis
P1 29 29 29 29
P2 25 23 23 23
P3 17 25 19 29
P4 27 and 29 29 21 23
P5 19 29 19 19
18 K.H. Madoueffects of different amplitudes and different application
times on muscular output should be the aim of future
studies.
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